Cite
HARVARD Citation
Angelopoulou, M. et al. (2018). Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience. Hematological oncology. 36 (1), pp. 174-181. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Angelopoulou, M. et al. (2018). Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience. Hematological oncology. 36 (1), pp. 174-181. [Online].